Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Return on Capital Employed (2022 - 2025)

Gossamer Bio's Return on Capital Employed history spans 4 years, with the latest figure at 1.34% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 114.0% year-over-year to 1.34%; the TTM value through Dec 2025 reached 1.34%, down 114.0%, while the annual FY2025 figure was 0.95%, 72.0% down from the prior year.
  • Return on Capital Employed reached 1.34% in Q4 2025 per GOSS's latest filing, down from 0.99% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.21% in Q4 2024 to a low of 1.34% in Q4 2025.
  • Average Return on Capital Employed over 4 years is 0.72%, with a median of 0.71% recorded in 2024.
  • Peak YoY movement for Return on Capital Employed: skyrocketed 98bps in 2024, then crashed -114bps in 2025.
  • A 4-year view of Return on Capital Employed shows it stood at 0.88% in 2022, then grew by 25bps to 0.66% in 2023, then soared by 68bps to 0.21% in 2024, then tumbled by -546bps to 1.34% in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Return on Capital Employed are 1.34% (Q4 2025), 0.99% (Q3 2025), and 0.7% (Q2 2025).